Early Toronto experience with new standards for industry-sponsored clinical research: a progress report
- PMID: 11873924
- PMCID: PMC99356
Early Toronto experience with new standards for industry-sponsored clinical research: a progress report
Comment in
-
Questions of interest.CMAJ. 2002 Feb 19;166(4):413, 415. CMAJ. 2002. PMID: 11873912 Free PMC article. No abstract available.
References
-
- Stelfox HT, Chau G, O'Rourke K, Detsky A. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998; 338:101-6. - PubMed
-
- Montaner JSG, O'Shaughnessy, Schechter, MT. Industry-sponsored clinical research: a double-edged sword. Lancet 2001;358:1893-5. - PubMed
-
- Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, et al. The uncertainty principle and industry-sponsored research. Lancet 2000;356:635-8. - PubMed
-
- Rochon PA, Gurwitz JH, Simms RW, Fortin PR, Felson DT, Minaker KL, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drug in the treatment of arthritis. Arch Intern Med 1994;154:157-63. - PubMed
-
- Johansen H, Gotzsche P. Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA 1999;282:1752-9. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources